Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Market Closed - NYSE 21:00:02 04/09/2026 BST			5-day change	1st Jan Change
51.64 ^USD	-0.54%		+2.50%	+39.72%

08-24	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
08-17	IMAX Posts $47 Million Global Weekend Boosted by 'The Odyssey'	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

e846c3dd.J9cuhTc2pVKahEF8C1mMB9zipUSVK1JPBF3u5sn8Vtk.eLte9kFs8ibD4XFIOynuYL2Q0QvNYxgFSy6f0fqWL5FFp3roAGLHK_nOcQ~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

08-24	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
07-24	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
07-24	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
07-24	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
07-24	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
07-16	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
07-16	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
07-10	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
05-18	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
05-04	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
05-01	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
04-23	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
04-17	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
02-27	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
02-26	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
02-26	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
12-15	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
12-08	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
12-08	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
12-08	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT
12-08	B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating	MT
11-25	Goldman Sachs Upgrades IMAX to Neutral From Sell, Adjusts Price Target to $34 From $22	MT
24/10/25	IMAX Reports 'Superb' Q3 Results, Wedbush Says	MT
20/10/25	US Box Office Set to Rebound in Fourth Quarter, B. Riley Says	MT
22/09/25	Imax Likely to Surpass 'Peak' EBITDA Margins in Two Years, Wedbush Says	MT

More recommendations

Other Entertainment Production

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
IMAX CORPORATION		+7.77%
WARNER MUSIC GROUP CORP.		+28.15%
TKO GROUP HOLDINGS, INC.		+24.27%
BOLLORÉ SE		+13.43%
SEGA SAMMY HOLDINGS INC.		-2.06%
TOEI ANIMATION CO.,LTD.		+3.53%
TOEI COMPANY, LTD.	-	-1.67%
HAVAS N.V.		+16.6%
Average		+11.25%
Weighted average by Cap.		+17.30%